Overview

A Study to Assess the Safety, Tolerability, and Efficacy of ION-827359 in Patients With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis (CB)

Status:
Terminated
Trial end date:
2021-04-27
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of ION-827359 on forced expiratory volume in 1 second (FEV1) in patients with mild to moderate COPD with CB.
Phase:
Phase 2
Details
Lead Sponsor:
Ionis Pharmaceuticals, Inc.